File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Control of shivering under regional anaesthesia in obstetric patients with tramadol

TitleControl of shivering under regional anaesthesia in obstetric patients with tramadol
Authors
Issue Date1999
PublisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/medicine/anesthesiology/journal/12630
Citation
Canadian Journal of Anaesthesia, 1999, v. 46 n. 3, p. 253-258 How to Cite?
AbstractPURPOSE: Tramadol in a dose of 1 mg x kg(-1) iv is effective in the treatment of shivering after general anesthesia. The current study aimed to investigate (1) whether tramadol was equally effective for shivering under regional anesthesia in obstetric patients and (2) whether effective treatment could be achieved with lower doses. METHODS: In a randomised, double-blind study, 36 obstetric patients who shivered during Cesarean section under regional anesthesia and who requested anti-shivering treatment were allocated to one of three groups for iv treatment: Group T0.5 received tramadol 0.5 mg x kg(-1) (n = 12), Group T0.25 tramadol 0.25 mg x kg(-1) (n = 13) and Group NS normal saline 0.05 ml x kg(-1) (n = 11). Treatment efficacy was evaluated subjectively by the parturient as no improvement, slight improvement, or marked improvement. The attending anesthesiologist who was blinded also independently noted the time elapsed from treatment to the time shivering subsided. Side effects such as nausea, vomiting or sedation and Apgar scores of the newborn were also noted. RESULTS: Eighty percent of parturients in Group T0.5 and 92% in Group T0.25 were judged by observers to have shivering controlled compared with 27% in Group NS (P < 0.001). The response rates of Group T0.5 and Group T0.25 were not different. There was no increased incidence of side effects in the treatment groups. CONCLUSION: We conclude that tramadol iv was effective in the treatment of intraoperative shivering during regional anesthesia for Cesarean section. There was no demonstrable difference in response rate or incidence of side effects between the two doses of 0.5 mg x kg(-1) and 0.25 mg x kg(-1).
Persistent Identifierhttp://hdl.handle.net/10722/67301
ISSN
2015 Impact Factor: 2.139
2015 SCImago Journal Rankings: 0.884
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChan, AMHen_HK
dc.contributor.authorNg, KFJen_HK
dc.contributor.authorTong, EWNen_HK
dc.contributor.authorJan, GSKen_HK
dc.date.accessioned2010-09-06T05:53:46Z-
dc.date.available2010-09-06T05:53:46Z-
dc.date.issued1999en_HK
dc.identifier.citationCanadian Journal of Anaesthesia, 1999, v. 46 n. 3, p. 253-258en_HK
dc.identifier.issn0832-610Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/67301-
dc.description.abstractPURPOSE: Tramadol in a dose of 1 mg x kg(-1) iv is effective in the treatment of shivering after general anesthesia. The current study aimed to investigate (1) whether tramadol was equally effective for shivering under regional anesthesia in obstetric patients and (2) whether effective treatment could be achieved with lower doses. METHODS: In a randomised, double-blind study, 36 obstetric patients who shivered during Cesarean section under regional anesthesia and who requested anti-shivering treatment were allocated to one of three groups for iv treatment: Group T0.5 received tramadol 0.5 mg x kg(-1) (n = 12), Group T0.25 tramadol 0.25 mg x kg(-1) (n = 13) and Group NS normal saline 0.05 ml x kg(-1) (n = 11). Treatment efficacy was evaluated subjectively by the parturient as no improvement, slight improvement, or marked improvement. The attending anesthesiologist who was blinded also independently noted the time elapsed from treatment to the time shivering subsided. Side effects such as nausea, vomiting or sedation and Apgar scores of the newborn were also noted. RESULTS: Eighty percent of parturients in Group T0.5 and 92% in Group T0.25 were judged by observers to have shivering controlled compared with 27% in Group NS (P < 0.001). The response rates of Group T0.5 and Group T0.25 were not different. There was no increased incidence of side effects in the treatment groups. CONCLUSION: We conclude that tramadol iv was effective in the treatment of intraoperative shivering during regional anesthesia for Cesarean section. There was no demonstrable difference in response rate or incidence of side effects between the two doses of 0.5 mg x kg(-1) and 0.25 mg x kg(-1).-
dc.languageengen_HK
dc.publisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/medicine/anesthesiology/journal/12630en_HK
dc.relation.ispartofCanadian Journal of Anaesthesiaen_HK
dc.rightsThe original publication is available at www.springerlink.com-
dc.subject.meshAnalgesics, Opioid - therapeutic use-
dc.subject.meshAnesthesia, Conduction-
dc.subject.meshAnesthesia, Obstetrical-
dc.subject.meshShivering - drug effects-
dc.subject.meshTramadol - therapeutic use-
dc.titleControl of shivering under regional anaesthesia in obstetric patients with tramadolen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0832-610X&volume=46&spage=253&epage=258&date=1999&atitle=Control+of+shivering+under+regional+anaesthesia+in+obstetric+patients+with+tramadolen_HK
dc.identifier.emailNg, KFJ: jkfng@hkucc.hku.hken_HK
dc.identifier.authorityNg, JKF=rp00544en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/BF03012605-
dc.identifier.pmid10210050-
dc.identifier.scopuseid_2-s2.0-0032923989-
dc.identifier.hkuros44312en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0032923989&selection=ref&src=s&origin=recordpage-
dc.identifier.volume46-
dc.identifier.issue3-
dc.identifier.spage253-
dc.identifier.epage258-
dc.identifier.isiWOS:000079092200010-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats